Drug intelligence / Profile preview

dyclonine

Development stage
Approved
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Oral
01

Overview

Dyclonine is a small molecule topical anesthetic primarily used for the temporary relief of pain and irritation in the mouth and throat. It is commonly found in over-the-counter lozenges (such as Sucrets) and topical solutions (such as DycloPro), where it acts to suppress the gag reflex prior to procedures or provide symptomatic relief from sore throats, canker sores, fever blisters, oral ulcers, stomatitis, and ano-genital lesions[1][3][4][7]. Its mechanism of action involves blocking both the initiation and conduction of nerve impulses by decreasing neuronal membrane permeability to sodium ions. This stabilizes the membrane reversibly and inhibits depolarization, resulting in failure of propagated action potentials—effectively producing local anesthesia[1]. The main molecular targets are sodium channel protein type 10 subunit alpha (SCN10A) and sodium channel protein type 5 subunit alpha[1]. Dyclonine is absorbed through mucous membranes with rapid onset when applied topically. It has also been used in veterinary medicine for similar purposes[6].

Brand names
DycloProSucrets
Other names
dyclonine hydrochloride
02

Targets

SCN10A (Sodium channel protein type X alpha subunit)TRPV3 (Transient receptor potential vanilloid subtype 3)SCN5A (Sodium channel protein type 5 subunit alpha)

Beyond the preview

Go deeper on dyclonine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dyclonine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call